{{Rsnum
|rsid=1632744
|Chromosome=5
|position=104863359
|Orientation=plus
|GMAF=0.4867
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 31.0 | 50.4 | 18.6
| HCB | 54.0 | 32.8 | 13.1
| JPT | 46.9 | 47.8 | 5.3
| YRI | 10.2 | 37.4 | 52.4
| ASW | 8.8 | 59.6 | 31.6
| CHB | 54.0 | 32.8 | 13.1
| CHD | 47.7 | 45.0 | 7.3
| GIH | 52.5 | 40.6 | 6.9
| LWK | 12.7 | 39.1 | 48.2
| MEX | 37.9 | 39.7 | 22.4
| MKK | 9.0 | 46.8 | 44.2
| TSI | 17.6 | 41.2 | 41.2
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=5E-6
  |OR=1.39
  |ORtxt=[0.959-2.007]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}